Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease characterised by myocyte loss with fibro-fatty replacement in the right and/or left ventricle. 1 Clinical presentation is with ventricular arrhythmias, congestive heart failure and sudden cardiac death. 2 The identification of mutations in five different desmosomal genes supports the hypothesis that ARVC is a disease of cell adhesion. Clinical diagnosis of ARVC is problematical and still relies on diagnostic criteria proposed over a decade ago. 9 A modification of these criteria has been proposed for the diagnosis of ARVC in the setting of a known family history, in which the risk of inheriting a disease-causing gene is 50%. 3 However, recent genotypeephenotype correlation studies have highlighted the fact that the former criteria lack sensitivity and the latter may lack specificity. 7 10 11 The 12-lead electrocardiogram (ECG) is an important diagnostic tool in ARVC. ECG features of ARVC include: (1) T-wave inversion (TWI) in right precordial leads (V1eV3) above the age of 12 years in the absence of right bundle branch block, found in 46e85% in the largest series; 12 13 (2) epsilon waves, present in up to 33% of ARVC patients; 12 14 (3) localised QRS prolongation greater than 110 ms in right precordial leads seen in up to 64% of patients and (4) QRS dispersion greater than 40 ms in 44%. 12 The aim of our study was to investigate the development/evolution of these ECG features in relation to other clinical characteristics in genotyped patients who ultimately fulfilled the diagnostic criteria for ARVC. Such an evaluation was prompted by the first author's observation of spontaneous variation in ECG diagnostic features while scanning tracings of ARVC mutation carriers onto the ARVC database.
METHODS
The electrocardiographic features of arrhythmogenic right ventricular cardiomyopathy were assessed in consecutive patients diagnosed with ARVC according to the task force criteria for probands (the presence of two major, one major and two minor or four minor from different categories was considered diagnostic) and proposed modified criteria for family members. 3 9 Patients were evaluated in a dedicated ARVC clinic at the Heart Hospital, University College London Hospital, London, by clinical history, 12-lead electrocardiogram, signal averaged electrocardiogram (SAECG), transthoracic echocardiography, maximal upright bicycle exercise testing, 24-h ECG 3 and, when necessary, by contrast echocardiography and/ or magnetic resonance imaging. Sixty-eight patients who fulfilled the following criteria were included in the study: at least two good-quality 12-lead ECG recorded a minimum of 6 months apart in the absence of significant change in QRS axis in limb leads and in QRS morphology/polarity (R/S ratio) in precordial leads (to avoid comparison of ECG with different precordial lead positions); complete bundle branch block at baseline; a ventricular paced rhythm; aged 12 years or less; obstructive coronary artery disease; treatment with class 1 antiarrhythmic agents. Cardiac structural and functional abnormalities were defined by echocardiography and, when clinically indicated, by cardiac magnetic resonance, according to the criteria proposed by McKenna et al 9 in 1994, and were classified as: major, when there was severe dilation (ie, $3 SD from normal range) and reduction in right ventricular ejection fraction and/or localised right ventricular aneurysm and/or severe right ventricular segmental dilatation; minor, when there was mild global right ventricular dilatation (ie, $2 and <3 SD from normal range) and/or mild right ventricular ejection fraction reduction and/or mild right ventricular segmental dilatation and/or regional right ventricular hypokinesia. 9 15 SAECG was considered abnormal when at least two of the following parameters were present using a 40 Hz high-pass filtering: filtered QRS duration greater than 114 ms; low-amplitude signal duration below 40 mV is greater than 38 ms; the root mean square voltage in the last 40 ms of the QRS is less than 20 mV.
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ECG analysis
The ECG were recorded according to international standards 17 at 25 mm/s and were enlarged two times in order to increase the accuracy of measurements; frequency filtering ranged from 0.05 to 0.5 Hz for low-frequency filtering and from 100 to 150 Hz for high-frequency filtering. ECG were analysed by GQ using digital callipers (SigmaScan Pro5 Demo; Systat, Chicago, Illinois, USA), without knowledge of the patient's clinical data. QRS duration was measured in the precordial leads from the beginning of the Q wave, or, in absence of the latter, from the beginning of the R wave to the end of the S wave, defined as its return to the TP baseline. The mean value of three consecutive complexes was used for the analysis. Four ECG features were investigated: (1) TWI in right precordial leads (V1eV3); (2) epsilon waves, electrical potentials of small amplitude that occur at the end of the QRS complex and at the beginning of the ST segment; 14 (3) localised QRS prolongation, defined when QRS duration was above 110 ms in right precordial leads (V1eV3); 9 18 (4) QRS dispersion, defined when the difference between the maximum and minimum QRS values in the precordial leads was above or equal to 40 ms. 13 19 Dynamic changes of ECG diagnostic features were defined by the presence and subsequent disappearance of any of the above electrocardiographic features during serial evaluation, ie., spontaneous fluctuations between diagnostic and non-diagnostic ECG abnormalities.
Statistical analysis
Continuous variables are reported as mean6SD and categorical variables are summarised as percentages. The reproducibility of the measurements of QRS intervals was assessed by two independent observers, blinded to the clinical data, in a random sample of 20 ECG. The percentage differences in QRS measurements ranged from 1% to 5% for within-observer variability and from 2% to 6% for between-observer variability. General agreement was obtained to define the presence of TWI in right precordial leads and epsilon waves in each patient (kappa value equals 1.0 according to Cohen's k test). Continuous variables were compared by use of the ManneWhitney U test. SPSS statistical software (SPSS Inc, version 12.0) was used for the statistical analysis.
RESULTS
Baseline patient characteristics
Baseline patient characteristics are shown in table 1. The study population of 68 patients was aged 17e74 years, mean 43.8 years. There were 33 men (48.5%). Patients were referred to the ARVC clinic for symptoms (n¼14, 20.6%) following an episode of documented, symptomatic ventricular tachycardia (n¼6, 8.8%), or ventricular fibrillation cardiac arrest (n¼3, 4.4%), or for family evaluation (n¼45, 66.2%). Thirty-one patients (45.6%) were asymptomatic at initial evaluation. Palpitation was the most common reported symptom (18 patients), followed by syncope (16 patients), shortness of breath (five patients) and chest pain (four patients). A family history of ARVC confirmed by autopsy and/or a clinical diagnosis of ARVC 9 in a family member was found in 56 (82.3%) patients. Right ventricular structural and functional abnormalities were considered to be major in 18 patients (26.5%) and minor in 40 (58.8%). At baseline, 27 patients (39.7%) had TWI beyond V2, four (5.9%) had epsilon waves, 10 (14.7%) had localised QRS prolongation of the QRS complex in V1eV3, and seven (10.3%) had QRS dispersion. At least one of these features was present in 37 of 68 (54.4%) patients at baseline. Thirty patients had left bundle branch block (LBBB)-type ventricular tachycardia (nine sustained ventricular tachycardia, 21 non-sustained ventricular tachycardia) and 32 (47.1%) had more than 1000 premature ventricular complexes (PVC), or more than 200 PVC in the context of familial disease 3 on 24-h ECG. Twenty-nine patients (42.6%) were taking antiarrhythmic therapy (amiodarone, b-blockers and/or sotalol).
Mutations considered to be disease-causing were identified in 34 patients (50.0%): in desmoplakin, 13 (19.1%); in plakophilin-2, 16 (23.5%); in desmoglein-2, four (5.9%) and in desmocollin-2, one (1.5%).
Follow-up
The patients were followed for 34.0628.7 months (range 7e166 months). Forty-one (60.3%) underwent implantable cardioverter defibrillator (ICD) implantation and three had ventricular tachycardia ablation for recurrent episodes of ventricular tachycardia.
A total of 317 ECG was analysed (a mean of five ECG per patient, range 2e13). ECG changes during follow-up were observed in 16 patients (23.5%), with the appearance of new ECG abnormalities in seven (10.3%) and with dynamic ECG changes in nine (13.2%) (figure 1). In particular, four of 41 patients without TWI in V1eV3 at baseline developed TWI in right precordial leads. Eight patients (11.8%), four with and four without TWI at baseline, showed dynamic changes in repolarisation in right precordial leads (figures 1e3); one of them developed complete LBBB. Three of 64 patients without epsilon waves at baseline developed new epsilon waves during follow-up (figure 1b). Three patients showed a dynamic presence of epsilon waves (figure 4). Two of these patients also had dynamic repolarisation changes. Ten patients (14.7%) showed localised QRS prolongation in right precordial leads at baseline and 58 did not; neither subset had dynamic changes during follow-up (figure 1c). Sixty-one patients (89.7%) without QRS dispersion and six patients (8.8%) with QRS dispersion at baseline had no significant changes of this feature during follow-up. One patient with dynamic changes of repolarisation waves in precordial leads also had a normalisation of QRS dispersion during follow-up ( figure 1d and figure 5 ). Table 2 summarises the clinical characteristics of the nine patients who showed dynamic ECG changes. Gene mutations considered to be disease-causing were found in four out of nine (44%) patients (two in desmoplakin and two in plakophilin-2). Every patient had either a family history of pathologically confirmed ARVC or clinical diagnosis of ARVC in a family member based on current diagnostic criteria. 9 The duration of follow-up of these patients was similar to those without dynamic changes (30.468.2 vs 34.6630.6 months, p¼0.413). The patients were aged 18e53 years. None had major structural abnormalities of the right ventricle. Two patients had evidence of left ventricular involvement. Patient no 7 had a left ventricular end-diastolic diameter 128% of predicted, with preserved left ventricular ejection fraction (60%) and no wall motion abnormalities. She and other members of her family carry a desmoplakin mutation (2034insA, T586fsX594), which is associated with ARVC and predominantly left ventricular involvement. 20 The other patient (no 8) had a left ventricular end-diastolic diameter 109% of predicted with 50e55% ejection fraction; she developed TWI in V1eV6. Three patients (nos 4, 7 and 9) had frequent PVC recorded during 24-h ECG (table 2). Three had palpitations as their initial clinical presentation of the disease, whereas the other six developed symptoms during follow-up. Worsening of palpitations and/or presyncopal episodes, either at rest or while exercising, influenced the decision for prophylactic ICD implantation in seven patients. In one patient (no 7) the disappearance of QRS dispersion during follow-up was mainly due to prolongation of QRS duration in left precordial leads, consistent with initial left ventricular involvement (figure 5). Two patients (nos 4 and 6), who experienced atypical chest pain, underwent coronary angiogram. The first showed normal coronary arteries; the latter demonstrated an abnormal origin of a small left coronary artery from the right coronary sinus, whereas a huge right coronary supplied most of the left and right ventricles; a dobutamine stress-echo showed no evidence of ischaemia. The finding of new or dynamic ECG changes was not associated with any particular disease-causing mutation (table 2) .
Clinical characteristics of patients with dynamic ECG changes
DISCUSSION
Since the first description of an ARVC cohort in 1982, 21 ECG abnormalities have been acknowledged as an important feature of disease expression, the most distinctive being TWI in right precordial leads (V1eV3) and 'postexcitation waves', later on called 'epsilon waves'.
14 Subsequently, additional diagnostic electrocardiographic features were proposed including the presence of localised QRS prolongation in V1eV3, 9 18 QRS and QT dispersion 19 and a delayed S-wave upstroke of 55 ms or greater in V1eV3, 12 although the value of the latter has been questioned as an early diagnostic marker. 22 Few studies have analysed the electrocardiographic changes over time in ARVC patients. 23 24 ECG changes noted during follow-up of ARVC patients have generally been perceived by investigators as evidence of disease progression, possibly reflecting areas of new myocardial involvement or progressive adverse remodelling. 23 25 Those studies included a higher percentage of symptomatic patients (up to 80% had sustained ventricular tachycardia), probably reflecting a referral bias. In our study, we performed a systematic analysis of serial 12-lead ECG available in a cohort of 68 patients who fulfilled the diagnostic criteria for ARVC, 13% of whom had sustained ventricular tachycardia. Our programme involves clinical evaluation of family members of probands with clinical or pathological diagnosis of ARVC. This enables recognition of a broader clinical spectrum of ARVC, including early/asymptomatic forms, and this may account for some of the differences between our and previous studies, in which up to 90% of patients had evidence of ECG progression. 23 25 Most patients showed either no changes or a progressive development of recognised ECG abnormalities of ARVC. Conversely, in a minority (13%), dynamic changes in T-wave polarity in right precordial leads, as well as in the presence of epsilon waves, were noted. QRS dispersion tended to be a more stable parameter and its disappearance (patient no 7) was mainly due to prolongation of QRS duration in V5eV6 ( figure 5 ). This observation raises the issue of the diagnostic sensitivity of QRS dispersion in later stages of the disease, when the involvement of the left ventricle may occur or in predominantly left ventricular forms of the disease. Similarly, no changes were noted in localised QRS prolongation in V1eV3 during follow-up. In contrast, a report from 1987 in 15 patients showed a significant increment of QRS duration over time. However, that study was performed before the current diagnostic criteria for ARVC were issued and included highly symptomatic patients with advanced disease. 26 Analysis of the clinical data of the ARVC patients with dynamic ECG changes revealed that none had major right ventricular structural or functional abnormalities, suggesting an early stage of the disease in this cohort (table 2) .
In a previous study on young sudden cardiac death victims, 27 dynamic ST elevation in right precordial leads (type 1 Brugada ECG pattern) was observed in five of six ARVC patients in whom at least two ECG were available, showing that dynamic ECG changes may also occur in structural heart disease. A transmural dispersion of repolarisation, most likely neurally mediated, from the diseased subepicardial layer and the relatively spared subendocardial muscle, has been advocated as a possible mechanism and may be partly associated with the dynamic ECG changes found in our population.
In recent years, a number of genetic 4e8 and pathological studies 28e30 have provided evidence that ARVC is mainly caused by dysfunction in desmosomes, specialised cellecell adhesion structures that anchor intermediate filaments to cell membranes. It has been hypothesised that malfunction of desmosomal proteins causes cell detachment in areas where the myocardium is subjected to intense and constant mechanical stress. Disruption of the mechanical desmosomal junction eventually leads to myocyte death with an inflammatory response and fibro-fatty replacement, the pathological hallmark of ARVC. 31 The dynamic ECG changes found in our study may reflect an active early phase of this process at a time when the mechanical defect causes electrical abnormalities in the absence of clinically detectable morphological changes. This hypothesis is supported by another clinical study, 24 which showed no correlation between electrocardiographic abnormalities and the extent and location of right ventricular involvement detected by echocardiography in a cohort of 20 patients. Gap junction remodelling described 32 in a young girl with Naxos disease, a recessive form of ARVC, and confirmed by another study 28 in dominant ARVC, may play a role in the phenomenon observed in our study. The young girl with Naxos disease died aged 7 years from a non-cardiovascular cause. She had typical ECG features of ARVC and frequent ventricular arrhythmias (>14 000 PVC on 24-h ECG), mainly of right ventricular origin, but no structural heart disease detectable by echocardiography. Her entire heart was examined by expert pathologists (G Thiene, J Saffitz), who could not identify macroscopic or microscopic features of ARVC. Immunohistochemical studies, however, revealed failure of appropriate localisation to the intercalated disc of plakoglobin and reduced expression of the important gap junction protein connexin-43. Spontaneous fluctuations between diagnostic and non-diagnostic ECG abnormalities have been described in inherited ion channel (table 2) shows an epsilon wave in V2 and T-wave inversions in V1eV3; (b) the epsilon wave is no longer present in the second ECG taken 15 months later.
disease, such as Brugada syndrome. 33 It may be hypothesised that dynamic ECG changes in ARVC are an early disease expression related to gap junction and desmosomal remodelling, in the absence of detectable clinical structural or functional alterations or the typical histological changes of fibro-fatty replacement. In contrast, when overt disease is present, ECG abnormalities may be stable or progressive, presumably because significant structural changes have occurred.
Limitations
The number of ECG available for each patient and the duration of the individual follow-up are limitations that may have led to an underestimation of the frequency of the dynamic ECG changes in patients with ARVC. Variable ECG filtering may have affected the detection of epsilon waves, but not the detection of dynamic TWI, which was the main dynamic electrocardiographic feature found in our ARVC cohort.
Clinical implications
The presence of dynamic ECG changes is important in the context of familial disease, in which it is recognised that isolated unexplained ECG abnormalities are common and may be an early marker of disease expression. This underscores the importance of serial evaluation, particularly in patients at increased risk of disease development, ie, first degree relatives. The presence of a normal ECG and normal imaging does not imply absence of disease expression, and serial evaluation, including ECG and Holter monitoring, is warranted. In this context, the ECG plays a key role and it may be more important than serial imaging evaluation at an early stage of the disease, when electrical abnormalities may be more evident than subtle structural changes.
CONCLUSIONS
This study demonstrates that some of the diagnostic ECG features of ARVC may de dynamic. These dynamic changes were not paralleled by progression of structural or functional right ventricular abnormalities. Recognition of these dynamic changes, albeit in a minority (13%), highlights the importance of serial evaluation for the diagnosis of ARVC. Larger cohorts with longer follow-up are needed to examine the clinical associations of dynamic ECG changes, but these preliminary data add further evidence to suggest that the clinical presentation of ARVC can be at a stage when electrophysiological manifestations of disrupted cell adhesion may precede clinical structural changes or histological evidence of the characteristic repair process of fibro-fatty replacement. 32 
